ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04060	Cytokine-cytokine receptor interaction	8/43	191/7206	1.37687056978e-05
ko05150	Staphylococcus aureus infection	4/43	36/7206	5.63671517271e-05
ko04664	Fc epsilon RI signaling pathway	5/43	77/7206	8.56525822193e-05
ko04514	Cell adhesion molecules (CAMs)	6/43	130/7206	0.00010828014411
ko05310	Asthma	3/43	17/7206	0.000126987332956
ko05416	Viral myocarditis	4/43	55/7206	0.000300592416
ko05340	Primary immunodeficiency	3/43	30/7206	0.000718282088877
ko04666	Fc gamma R-mediated phagocytosis	5/43	122/7206	0.000737170708406
ko05152	Tuberculosis	6/43	187/7206	0.000772621503106
ko05169	Epstein-Barr virus infection	6/43	206/7206	0.00127891588321
ko04672	Intestinal immune network for IgA production	3/43	37/7206	0.00133526710406
ko05144	Malaria	3/43	45/7206	0.00235897998207
ko04064	NF-kappa B signaling pathway	4/43	96/7206	0.00245275665935
ko04650	Natural killer cell mediated cytotoxicity	4/43	97/7206	0.00254724789013
ko05321	Inflammatory bowel disease (IBD)	3/43	56/7206	0.00440314363301
ko04062	Chemokine signaling pathway	5/43	201/7206	0.00653601924593
ko05166	HTLV-I infection	6/43	292/7206	0.00724323126149
ko05330	Allograft rejection	2/43	24/7206	0.00883327613
ko05140	Leishmaniasis	3/43	75/7206	0.00991700004493
ko04612	Antigen processing and presentation	3/43	77/7206	0.0106549846257
ko05320	Autoimmune thyroid disease	2/43	29/7206	0.0127514419104
ko05133	Pertussis	3/43	87/7206	0.0148169679321
ko04662	B cell receptor signaling pathway	3/43	88/7206	0.0152770194269
ko05323	Rheumatoid arthritis	3/43	89/7206	0.0157451243858
ko04658	Th1 and Th2 cell differentiation	3/43	96/7206	0.0192485729339
ko04620	Toll-like receptor signaling pathway	3/43	100/7206	0.0214296370985
ko04659	Th17 cell differentiation	3/43	106/7206	0.024946514198
ko05145	Toxoplasmosis	3/43	126/7206	0.0387890640204
ko04630	Jak-STAT signaling pathway	3/43	132/7206	0.0435696291069
ko04380	Osteoclast differentiation	3/43	134/7206	0.0452263546296